Discovery Genomics operates within an innovative and ethical business structure to provide transformative personalized patient care. We focus on pharmacogenomics (PFX), whole genome sequencing (WGS) and cancer tissue genomic research to align therapies and optimize personalized population health care.
In 2020, we evolved our services to help impact the trajectory of the pandemic by offering COVID-19 testing services. By retooling our high complexity CLIA-certified lab, we can now process 10,000 COVID-19 tests daily with the highest level of accuracy.
COVID-19 Testing
Providing reliable results for patients, healthcare heroes, the workforce, and other groups requiring testing.
COVID-19 Lab Consulting
Ask the experts in adapting capabilities and optimizing operations to meet new challenges.
Tumor Sequencing
Explore how deeper understanding of a tumor provides depth to treatment guidance.
Unique Lab Capabilities
Pharmacogenomics (PGx)
Genetic testing and analysis provides guidance that makes medicine safer and more effective.
Whole Genome Sequencing (WGS)
The Genome tells the story. Ancestry and answers from the past; possibilities and precautions from the future.
Cancer Treatment Optimization
With a growing biobank and the latest technology, we are cracking the code to treatment optimization.